Frontier Biotechnologies Inc. (SHA:688221)
China · Delayed Price · Currency is CNY 14.06
+0.45 (3.31%)
At close: Oct 23, 2026
Frontier Biotechnologies Revenue
Frontier Biotechnologies had revenue of 16.16M CNY in the quarter ending June 30, 2026, a decrease of -46.67%. This brings the company's total for the last twelve months to 378.04M, up 175.83% year-over-year. In the year 2025, Frontier Biotechnologies had annual revenue of 123.39M, down -4.70%. That makes Frontier Biotechnologies the 27,023rd largest company in the world by revenue and 4,719th in China.
Revenue (ttm)
378.04M
Revenue Growth
+175.83%
P/S Ratio
13.93
Revenue / Employee
1.43M
Employees
265
Market Cap
5.27B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 123.39M | -6.09M | -4.70% |
| Dec 31, 2024 | 129.47M | 15.22M | 13.32% |
| Dec 31, 2023 | 114.25M | 29.51M | 34.82% |
| Dec 31, 2022 | 84.74M | 44.24M | 109.22% |
| Dec 31, 2021 | 40.50M | -6.12M | -13.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.